Show simple item record

dc.contributor.authorFeldman, Adinaen
dc.contributor.authorGriffin, Simonen
dc.contributor.authorFhärm, Een
dc.contributor.authorNorberg, Men
dc.contributor.authorWennberg, Pen
dc.contributor.authorWeinehall, Len
dc.contributor.authorRolandsson, Oen
dc.description.abstractAims/hypothesis We aimed to investigate whether diabetes cases detected through screening have better health outcomes than clinically detected cases in a population-based cohort of adults who were eligible to be screened for diabetes at 10 year intervals. Methods The Västerbotten Intervention Programme is a community- and individual-based public health programme in Västerbotten County, Sweden. Residents are invited to clinical examinations that include screening for diabetes by OGTTs at age 30, 40, 50 and 60 years (individuals eligible for screening, n = 142,037). Between 1992 and 2013, we identified 1024 screen-detected cases and 8642 clinically detected cases of diabetes using registry data. Clinically detected individuals were either prior screening participants (n = 4506) or people who did not participate in screening (non-participants, n = 4136). Study individuals with diabetes were followed from date of detection until end of follow-up, emigration, death or incident cardiovascular disease (CVD), renal disease or retinopathy event, and compared using Cox proportional hazard regression adjusted for calendar time, age at detection, year of detection, sex and socioeconomic status. Results The average age at diabetes diagnosis was 4.6 years lower for screen-detected individuals compared with clinically detected individuals. Overall, those who were clinically detected had worse health outcomes than those who were screen-detected (HR for all-cause mortality 2.07 [95% CI 1.63, 2.62]). Compared with screen-detected study individuals, all-cause mortality was higher for clinically detected individuals who were screening non-participants (HR 2.31 [95% CI 1.82, 2.94]) than for those clinically detected who were prior screening participants (HR 1.70 [95% CI 1.32, 2.18]). Estimates followed a similar pattern for CVD, renal disease and retinopathy. Conclusions/interpretation Individuals with screen-detected diabetes were diagnosed earlier and appeared to fare better than those who were clinically detected with regard to all-cause mortality, CVD, renal disease and retinopathy. How much of these associations can be explained by earlier treatment because of screening rather than healthy user bias, lead time bias and length time bias warrants further investigation.
dc.description.sponsorshipThis work was supported by the Medical Research Council (MC_UU_12015/4), the Swedish Council for Working Life and Social Research (FAS 2006_1512) and the Swedish Research Council (2006-21576-36119-666). The VIP is financed by Västerbotten County Council. ALF is supported by the Raymond and Beverly Sackler Foundation through Churchill College, Cambridge.
dc.publisherSpringer Nature
dc.rightsAttribution 4.0 Internationalen
dc.rightsAttribution 4.0 Internationalen
dc.subjectDiabetes mellitusen
dc.subjectEarly diagnosisen
dc.subjectMass screeningen
dc.subjectPublic healthen
dc.titleScreening for type 2 diabetes: Do screen-detected cases fare better?en
dc.contributor.orcidFeldman, Adina [0000-0002-9388-6896]
dc.contributor.orcidGriffin, Simon [0000-0002-2157-4797]
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idMRC (MC_UU_12015/4)
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10119)
cam.orpheus.successThu Jan 30 12:58:21 GMT 2020 - The item has an open VoR version.*

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International